Skip to main content
. Author manuscript; available in PMC: 2013 May 30.
Published in final edited form as: Optom Vis Sci. 2011 Aug;88(8):1005–1009. doi: 10.1097/OPX.0b013e31821ddc6c

Table 2.

Clinical Summary of Ocular Cicatricial Pemphigoid Patients.

Patient No./Sex/Age, y Clinical Findings Systemic Disease IMT Time on IMT prior to follow- up tear collection (months) Schirmer’s Strip Results (mm) Pre-IMT (OD, OS) and Post-IMT (OD, OS)
OCP1/F/84 Diffuse bulbar conjunctival injection, subepithelial scarring Oral mucous membrane pemphigoid Cyclophosphamide 2 16, 16 (Pre)
26, 25 (Post)
OCP2/M/69 Conjunctival bullae, fornix shortening, inferior symblepharon Non-small cell lung carcinoma Radiation, Cisplatin, Etoposide, Prednisone, Mycophenolate mofetil 4 5, 8 (Pre)
35, 12 (Post)
OCP3/M/58 Irregular corneal epithelium, fornix shortening, symblepharon None Cyclophosphamide, oral prednisone, topical prednisolone 1 and 2 15, 12 (Pre)
20, 1 (1 m Post)
5, 5 (2 m Post)
OCP4/F/77 Diffuse bulbar conjunctival injection, subepithelial scarring, symblepharon Rheumatoid arthritis, chronic myelogenous leukemia (CML) Prednisone, Methotrexate 2 8, 6 (Pre)
10, 6 (Post)